Paperpal Prime Logo

Tissue Engineering - Part C: Methods : Impact Factor & More

eISSN: 1937-3392pISSN: 1937-3384

Key Metrics

CiteScore
5.8
Impact Factor
< 5
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Tissue Engineering - Part C: Methods Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • Inspec Inspec
  • SJR SJR
Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Tissue Engineering - Part C: Methods ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Tissue Engineering - Part C: Methods

0.1% Peracetic AcidTreatment Is the Optimal Process for Ovarian Decellularized Extracellular Matrix.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Generation and Characterization of Induced Pluripotent Stem Cell Line UAEUi001-A from an Emirati Patient with Ventricular Septal Defect.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Design and Fabrication of Demountable 3D Microphysiological Systems.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Automated Abnormal Vessel Detection in Re-Endothelialized Mouse Lungs: A Proof of Concept.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Clonal Lineage Tracing Reveals Distinct Invasive Subpopulations in Triple-Negative Breast Cancer.
  • 1 May 2026
  • Tissue engineering. Part C, Methods
A Defined 3D Hydrogel Model Recapitulates Key Transcriptomic Features of Lung Adenocarcinoma.
  • 1 May 2026
  • Tissue engineering. Part C, Methods
0.1% Peracetic AcidTreatment Is the Optimal Process for Ovarian Decellularized Extracellular Matrix.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Generation and Characterization of Induced Pluripotent Stem Cell Line UAEUi001-A from an Emirati Patient with Ventricular Septal Defect.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Design and Fabrication of Demountable 3D Microphysiological Systems.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Automated Abnormal Vessel Detection in Re-Endothelialized Mouse Lungs: A Proof of Concept.
  • 1 Jun 2026
  • Tissue engineering. Part C, Methods
Clonal Lineage Tracing Reveals Distinct Invasive Subpopulations in Triple-Negative Breast Cancer.
  • 1 May 2026
  • Tissue engineering. Part C, Methods
A Defined 3D Hydrogel Model Recapitulates Key Transcriptomic Features of Lung Adenocarcinoma.
  • 1 May 2026
  • Tissue engineering. Part C, Methods

FAQs on Tissue Engineering - Part C: Methods